Lithium and Valproate Levels Do Not Correlate with Ketamine’s Antidepressant Efficacy in Treatment-Resistant Bipolar Depression
Neural Plasticity 2015 Annie J. Xu, Mark J. Niciu, Nancy B. Lundin et al. 27 citations
Ketamine and lithium both inhibit glycogen synthase kinase 3. In addition, lithium and ketamine have synergistic antidepressant-like effects at individually subeffective doses in rodents. We hypothesized that ketamine's antidepressant effects would be improved by therapeutic doses of lithium versus valproate and that serum lithium levels would positively correlate with ketamine's antidepressant...
DOI: 10.1155/2015/858251 (opens in new tab)
Full text (opens in new tab)
Ketamine
Lithium medication
Algorithm
Pharmacology
+1